In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation

18Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background/Aim: MK615 extracted from Prunus mume was reported to have anti-inflammatory effects. In this article, we examined the in vivo antitumor effect of MK615 (an extract from Japanese apricot) using mouse tumor xenografts and focusing on the downregulation of PD-L1 (programmed death-ligand 1), a ligand of programmed cell death-1, a surface protein of activated T cells. Materials and Methods: B16/BL6 melanoma cells were injected into C57BL/6 or BALB/c-nu/nu mice to establish lung metastasis. BALB/c-nu/nu mice (nude mice) were used as a T cell–deficient model. The mice were given MK615 or saline orally every other day for approximately 8 weeks, and their survival was observed. NF-κB (nuclear factor-κB) and PD-L1 expressions of metastatic lung tissues were also examined. Results: The survival rate was improved only in the MK615-treated C57BL/6 mice (P

Author supplied keywords

Cite

CITATION STYLE

APA

Yanaki, M., Kobayashi, M., Aruga, A., Nomura, M., & Ozaki, M. (2018). In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation. Integrative Cancer Therapies, 17(3), 646–653. https://doi.org/10.1177/1534735418766403

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free